Table 3.

Relationship between the expression of AR, MMPs and TIMPs by each cellular type in breast cancer.

Factor	N	AR score values median (range)	p value
MMP-1
TC (-) vs. (+)	7/104	0(0–70)/80(0–288)	0.004
FC (-) vs. (+)	14/97	2.5(0–225)/80(0–288)	0.03
MIC (-) vs. (+)	30/81	53(0–225)/81(0–288)	n.s.
MMP-2
TC (-) vs. (+)	70/41	59.5(0–279)/90(0–288)	n.s.
FC (-) vs. (+)	83/28	69(0–288)/88(0–270)	n.s.
MIC (-) vs. (+)	108/3	68.5(0–288)/66(0–132)	n.s.
MMP-7
TC (-) vs. (+)	8/103	0(0–156)/80(0–288)	0.01
FC (-) vs. (+)	27/84	68(0–267)/74.5(0–288)	n.s.
MIC (-) vs. (+)	50/61	66(0–267)/81(0–288)	n.s.
MMP-9
TC (-) vs. (+)	27/84	48(0–270)/80.5(0–288)	n.s.
FC (-) vs. (+)	93/18	68(0–288)/83.5(0–270)	n.s.
MIC (-) vs. (+)	98/13	80(0–279)/30(0–288)	n.s.
MMP-11
TC (-) vs. (+)	11/100	8(0–168)/80(0–288)	0.03
FC (-) vs. (+)	33/78	53(0–264)/81(0–288)	n.s.
MIC (-) vs. (+)	72/39	68(0–270)/87(0–288)	n.s.
MMP-13
TC (-) vs. (+)	29/82	48(0–225)/74.5(0–288)	n.s.
FC (-) vs. (+)	54/57	56(0–267)/81(0–288)	n.s.
MIC (-) vs. (+)	70/41	64.5(0–279)/92(0–288)	n.s.
MMP-14
TC (-) vs. (+)	10/101	64.5(0–273)/69(0–288)	n.s.
FC (-) vs. (+)	21/90	92(0–273)/66.5(0–288)	n.s.
MIC (-) vs. (+)	50/61	64.5(0–273)/81(0–288)	n.s.
TIMP-1
TC (-) vs. (+)	6/105	0(0–225)/72(0–288)	n.s.
FC (-) vs. (+)	56/55	70(0–288)/69(0–273)	n.s.
MIC (-) vs. (+)	81/30	64(0–279)/96(0–288)	n.s.
TIMP-2
TC (-) vs. (+)	13/98	0(0–174)/80(0–288)	0.01
FC (-) vs. (+)	59/52	80(0–270)/63(0–288)	n.s.
MIC (-) vs. (+)	63/48	80(0–288)/68.5(0–279)	n.s.
TIMP-3
TC (-) vs. (+)	15/96	48(0–210)/76(0–288)	n.s.
FC (-) vs. (+)	42/69	50.5(0–225)/88(0–288)	n.s.
MIC (-) vs. (+)	53/58	64(0–279)/87(0–288)	n.s.